Arkolith/Insider Trading/FDMT/Form 4

Bizily Scott

Chief Legal Officer4D Molecular Therapeutics, Inc. (FDMT) · full profile →Form 4 · filed Aug 21, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8K
Net Open-Market Flow
-$8K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 19, 2024Option exercise(M)500$6.49$3K7K
Aug 19, 2024Sell(S)500$15.00$8K7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 19, 2024Option exercise(M)500—$011K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-099505) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML